Related Experiment Video
Updated: Jul 8, 2026
23:06
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Management of multidrug-resistant tuberculosis: Update 2007
1Tuberculosis and Chest Unit, Grantham Hospital, Hong Kong, China. yewww@ha.org.hk
Respirology (Carlton, Vic.)
|January 17, 2008
Summary
Multidrug-resistant tuberculosis (MDR-TB) requires specialized DOTS-Plus strategies for treatment. Extensively drug-resistant tuberculosis (XDR-TB) presents a global health crisis demanding new drugs and strengthened control programs.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Multidrug-resistant tuberculosis (MDR-TB) is a global health concern.
- Resistance to isoniazid and rifampicin defines MDR-TB.
- Extensively drug-resistant tuberculosis (XDR-TB) shows additional resistance to fluoroquinolones and injectables.
Purpose of the Study:
- To highlight the challenges posed by MDR-TB and XDR-TB.
- To emphasize the importance of DOTS and DOTS-Plus strategies.
- To advocate for the development of new anti-TB drugs.
Main Methods:
- Review of current tuberculosis control strategies.
- Analysis of treatment outcomes for MDR-TB and XDR-TB.
- Discussion of drug resistance patterns and challenges.
Main Results:
- MDR-TB and XDR-TB necessitate specialized treatment regimens.
- Second-line drugs for MDR-TB are often less effective and more toxic.
- XDR-TB has a high mortality rate and low cure rate.
Conclusions:
- Strengthening DOTS and DOTS-Plus programs is crucial for combating MDR-TB and XDR-TB.
- Development of new, affordable, and effective anti-TB drugs is urgently needed.
- Addressing co-infections like HIV is vital for TB control.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
01:29Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
01:26Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...